Named on 7 rounds in the feed, most often at Series D+ and in Biotech.
Rounds from 2024-11-06 to 2026-09-11
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Precision Neuroscience A brain–computer interface (BCI) technology company | Series D Developing, 46 sources | $250M | 2026-09-11 | [ PART ] |
Fab2 A semiconductor company rethinking manufacturing by designing its own fabrication tools | Series A Verified against 4 of 14 sources | $500M | 2026-09-09 | [ PART ] |
Cellares Cellares specializes in advanced manufacturing technologies for cell therapy, targeting biopharmaceutical companies and healthcare providers. | Series D Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $50M | 2026-06-15 | [ PART ] |
SonoThera SonoThera develops innovative ultrasound-mediated nonviral genetic therapies targeting various medical conditions. | Series B Verified against 1 of 7 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $125M | 2026-06-10 | [ PART ] |
Cellares Cellares specializes in advanced manufacturing technologies for cell therapy, targeting biopharmaceutical companies and healthcare providers. | Series D Verified against 1 of 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $257M | 2026-01-28 | [ PART ] |
Curative Curative sells a health insurance plan with no copays or deductibles to employers and their employees. | Series B Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $150M | 2025-12-02 | [ PART ] |
Precision Neuroscience A brain–computer interface (BCI) technology company | Series C Verified against 1 of 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $102M | 2024-11-06 | [ PART ] |